Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026) Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
Mirage | $75,000,000 | (Mar 27, 2026)
Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)